Why Oppenheimer Global fund is focusing on biotech as rates rise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Equifax (EFX) Tops Q4 EPS by 7c, Beats on Revenues
March 1, 2018 4:41 PM ESTNote: EPS may not be comparable
Equifax (NYSE: EFX) reported Q4 EPS of $1.42, $0.07 better than the analyst estimate of $1.35. Revenue for the quarter came in at $838.5 million versus the consensus estimate of $825.69 million.
Financial Results Summary
The company reported revenue of $838.5 million in the fourth quarter of 2017, a 5 percent increase from the fourth quarter of 2016 and a 4 percent increase in local currency.Fourth quarter diluted EPS attributable to Equifax was $1.42, an increase of 40 percent as compared to the fourth quarter of 2016. Net income attributable to Equifax of $172.3 million was up 40... More